This is a routine proxy filing with no earnings or operational updates. Monitor the AGM outcome for any shareholder dissent on related-party compensation items, but no near-term trading catalyst is expected.
Price Chart
Executive Summary
Pulsenmore filed a 6-K furnishing its proxy statement for the June 16, 2026 Annual General Meeting. The agenda includes routine director re-elections, approval of the CEO's 2026 bonus plan (with targets tied to cash burn, sales, fundraising, and FDA milestones), discretionary bonus payments for 2025 to the CEO ($22,500) and VP R&D ($3,500), and an amended compensation policy raising maximum salary and bonus ceilings. This is a routine governance filing with no material financial data, no earnings release, and no change to the company's financial outlook.
Key Facts
- Annual General Meeting scheduled for June 16, 2026, with record date May 12, 2026.
- Proposal to re-elect Rachel Guz-Lavi and elect Hagai Itkin as Class I directors.
- CEO 2026 bonus plan targets include cash burn control, system sales (US and ex-US), fundraising, FDA study initiation, and factory relocation.
- Discretionary 2025 bonus of NIS 77,625 (~$22,500) for CEO Dr. Elazar Sonnenschein and NIS 12,075 (~$3,500) for VP R&D Menashe Sonnenschein.
- Amended compensation policy raises CEO max monthly salary from NIS 130,000 to NIS 200,000 and max annual bonus from NIS 780,000 to NIS 900,000.
- Directors' annual fee set at NIS 509,000 (~$172,000) and per-meeting fee of NIS 4,000 (~$1,000).
- Re-appointment of PwC as independent auditor for FY2026; audit fees were $184K in 2025 vs $56K in 2024.
- Outstanding shares: 6,502,844 as of April 30, 2026; CEO/controlling shareholder owns 28.2%.
Financial Impact
No material financial impact. Discretionary bonuses total ~$26,000. Compensation policy increases are ceiling adjustments, not guaranteed payments.
Risk Factors
- Potential shareholder dissent on CEO/controlling shareholder bonus plans and compensation increases.
- CEO 2026 bonus plan includes a 20% weight on fundraising, signaling potential future dilution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-021745 |
| Exhibit: ex99-2.htm | 0001493152-26-021745 |
| Document: form6-k.htm | 0001493152-26-021745 |
| Document: 0001493152-26-021745-index-headers.html | 0001493152-26-021745 |
| Document: 0001493152-26-021745-index.html | 0001493152-26-021745 |
| Document: 0001493152-26-021745.txt | 0001493152-26-021745 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.90 | awaiting T+20 | — | $1.73 (−8.95%) |
Oct 8, 2026 18d ago | SC 13G | $1.85 | awaiting T+20 | — | $1.73 (−6.49%) |
Sep 17, 2026 5w ago | 6-K | $2.42 $1.81 | ▼ −25.21% | ▼ −26.41% | $1.73 (−28.51%) |
Sep 8, 2026 6w ago | 6-K | $2.46 $2.16 | ▼ −12.20% | ▼ −13.91% | $1.73 (−29.67%) |
Sep 2, 2026 7w ago | EFFECT | $2.55 $2.22 | ▲ +12.94% | ▲ +12.86% | $1.73 (+32.16%) |
Aug 31, 2026 8w ago | 6-K | $2.62 $2.19 | ▼ −16.41% | ▼ −16.22% | $1.73 (−33.97%) |
Aug 19, 2026 9w ago | 6-K | $3.01 $2.42 | ▼ −19.60% | ▼ −18.76% | $1.73 (−42.52%) |
Aug 17, 2026 10w ago | 6-K | $2.89 $2.41 | ▼ −16.61% | ▼ −14.63% | $1.73 (−40.14%) |
Jul 13, 2026 15w ago | 6-K | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.73 (−52.21%) |
Jul 13, 2026 15w ago | EFFECT | $3.62 $3.26 | ▼ −9.94% | ▼ −13.13% | $1.73 (−52.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers